WO2012029731A1 - 細胞培養基材の製造方法 - Google Patents
細胞培養基材の製造方法 Download PDFInfo
- Publication number
- WO2012029731A1 WO2012029731A1 PCT/JP2011/069510 JP2011069510W WO2012029731A1 WO 2012029731 A1 WO2012029731 A1 WO 2012029731A1 JP 2011069510 W JP2011069510 W JP 2011069510W WO 2012029731 A1 WO2012029731 A1 WO 2012029731A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polymer
- monomer
- cell culture
- coating layer
- meth
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
Definitions
- the present invention relates to a method for producing a cell culture substrate. More specifically, the present invention relates to a method for producing a cell culture substrate that can be suitably used for regenerating cells having a shape corresponding to the shape of a tissue to be regenerated.
- ES cells embryonic stem cells
- iPS cells induced pluripotent stem cells
- precursor cells etc.
- a medium composed of a flat substrate is generally used.
- a monomer composition containing N-methacryloyloxyethyl-N, N-dimethylammonium- ⁇ -N-methylcarboxybetaine as a material having excellent biocompatibility that can be suitably used for this medium.
- a medical material having an obtained polymer brush on a substrate surface has been proposed (for example, see Patent Document 1).
- the medical material has a small interaction with biological components such as proteins and blood cells and is excellent in biocompatibility.
- biological components such as proteins and blood cells
- cells can be easily cultured in any shape on the medical material, it is expected to greatly contribute to regenerative medicine.
- cells can be cultured in any shape on the medical material. Since a method capable of easily producing a cell culture substrate that can be produced has not been established, the development of the method is urgently required.
- This invention is made
- the present invention (1) A method for producing a cell culture substrate in which a polymer coating layer is formed on the surface of the substrate, wherein the polymer is represented by the formula (I):
- R 1 is a hydrogen atom or a methyl group
- R 2 is an alkylene group having 1 to 6 carbon atoms
- R 3 and R 4 are each independently an alkyl group having 1 to 4 carbon atoms
- R 5 is an alkyl group having 1 carbon atom
- Y represents an oxygen atom or —NH— group
- the monomer component further includes an alkyl (meth) acrylamide monomer, a polyoxyalkylene (meth) acrylate monomer, a sugar skeleton-containing monomer, a phosphobetaine monomer, and a sulfobetaine monomer.
- the method for producing a cell culture substrate according to (1) above which contains at least one copolymerizable monomer selected from the group consisting of monomers; (3) The method for producing a cell culture substrate according to (1) or (2) above, wherein a polymer coating layer is formed by polymerizing a monomer component on the surface of the substrate, and (4) The present invention relates to a cell culture substrate obtained by the method for producing a cell culture substrate according to any one of (1) to (3).
- a cell culture substrate capable of culturing cells in an arbitrary shape can be easily produced.
- the method for producing a cell culture substrate of the present invention is a method for producing a cell culture substrate in which a polymer coating layer is formed on the surface of the substrate, and the polymer is represented by the formula (I). :
- R 1 is a hydrogen atom or a methyl group
- R 2 is an alkylene group having 1 to 6 carbon atoms
- R 3 and R 4 are each independently an alkyl group having 1 to 4 carbon atoms
- R 5 is an alkyl group having 1 carbon atom
- Y represents an oxygen atom or —NH— group
- a polymer obtained by polymerizing a monomer component containing a nitrogen atom-containing monomer is used as the polymer, and further, an ion beam is irradiated to a predetermined position of the coating layer of the polymer.
- an ion beam is irradiated to a predetermined position of the coating layer of the polymer.
- cells are cultured using this cell culture substrate, cells are cultured because the polymer is not present at the location irradiated with the ion beam, but the polymer is present without being irradiated with the ion beam. Since the cells are not cultured at the locations where they are, the cells can be cultured in a predetermined shape.
- R 1 is a hydrogen atom or a methyl group.
- R 2 is an alkylene group having 1 to 6 carbon atoms, preferably an alkylene group having 1 to 4 carbon atoms, more preferably an alkylene group having 1 or 2 carbon atoms, and still more preferably an alkylene group having 2 carbon atoms. It is. Specific examples of R 2 include a methylene group, an ethylene group, n- propylene, isopropylene, n- butylene, isobutylene group, and tert- butylene group, the present invention is limited only to those exemplified Is not to be done. Among these alkylene groups having 1 to 6 carbon atoms, a methylene group and an ethylene group are preferable, and an ethylene group is more preferable.
- R 3 and R 4 are each independently an alkyl group having 1 to 4 carbon atoms.
- the alkyl group having 1 to 4 carbon atoms include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, and a tert-butyl group. It is not limited to illustration only.
- a methyl group and an ethyl group are preferable, and a methyl group is more preferable.
- R 5 is an alkylene group having 1 to 4 carbon atoms.
- the alkylene group having 1 to 4 carbon atoms include a methylene group, an ethylene group, an n-propylene group, an isopropylene group, an n-butylene group, an isobutylene group, and a tert-butylene group. It is not limited only to such illustration.
- a methylene group and an ethylene group are preferable, and a methylene group is more preferable.
- Y is an oxygen atom or —NH— group.
- the nitrogen atom-containing monomer represented by the formula (I) has a concept including a hydrate. Therefore, the concept of the nitrogen atom-containing monomer represented by the formula (I) includes not only the nitrogen atom-containing monomer represented by the formula (I) but also a hydrate such as its monohydrate. It is.
- Examples of the nitrogen atom-containing monomer represented by the formula (I) include N- (meth) acryloyloxyethyl-N, N-dimethylammonium- ⁇ -N-methylcarboxybetaine, N- (meth) acryloyloxypropyl. -N, N-dimethylammonium- ⁇ -N-methylcarboxybetaine, N- (meth) acryloylaminoethyl-N, N-dimethylammonium- ⁇ -N-methylcarboxybetaine, N- (meth) acryloylaminopropyl-N , N-dimethylammonium- ⁇ -N-methylcarboxybetaine and the like, but the present invention is not limited to such examples.
- These nitrogen atom-containing monomers may be used alone or in combination of two or more.
- “(meth) acryloyl” means “acryloyl” and / or “methacryloyl”.
- N-methacryloyloxyethyl-N, N-dimethylammonium- ⁇ -N-methylcarboxybetaine is, for example, disclosed in JP-A-9-95474, JP-A-9-95586, and JP-A-11-222470. Can be easily prepared with high purity.
- the monomer component may be composed only of the nitrogen atom-containing monomer represented by the formula (I), and is a monomer copolymerizable with the nitrogen atom-containing monomer (hereinafter referred to as “copolymerizable”). May be referred to as a “monomer”.
- copolymerizable monomers examples include alkyl (meth) acrylamide monomers, polyoxyalkylene (meth) acrylate monomers, sugar skeleton-containing monomers, phosphobetaine monomers, and sulfobetaine monomers. A monomer etc. are mentioned, These copolymerizable monomers may be used independently, respectively and may use 2 or more types together.
- alkyl (meth) acrylamide monomer When an alkyl (meth) acrylamide monomer is contained in the monomer component, there is an advantage that the hydrolysis resistance of the resulting polymer can be improved.
- alkyl (meth) acrylamide monomer examples include N-methyl (meth) acrylamide, N-ethyl (meth) acrylamide, N-propyl (meth) acrylamide, N-isopropyl (meth) acrylamide, N-tert- Examples include butyl (meth) acrylamide, N-octyl (meth) acrylamide, N, N-dimethyl (meth) acrylamide, N, N-diethyl (meth) acrylamide and the like, but the present invention is limited to such examples.
- alkyl (meth) acrylamide monomers may be used alone or in combination of two or more.
- alkyl (meth) acrylamide monomers N-propyl (meth) acrylamide and N-isopropyl (meth) acrylamide are preferred, N-isopropyl (meth) acrylamide is more preferred, and N-isopropylacrylamide is further preferred.
- “(meth) acrylamide” means “acrylamide” and / or “methacrylamide”.
- the polyoxyalkylene (meth) acrylate monomer has a property of suppressing cell adhesion to the resulting polymer.
- Examples of the polyoxyalkylene (meth) acrylate monomer include 2-methoxyethyl (meth) acrylate, 2-ethoxyethyl (meth) acrylate, methoxytriethylene glycol (meth) acrylate, and methoxytetraethylene glycol (meth).
- Polyoxyethylene (meth) acrylate monomers such as acrylate, methoxypolyethylene glycol (meth) acrylate, polyethylene glycol mono (meth) acrylate; 2-methoxy-2-methylethyl (meth) acrylate, 2-ethoxy-2- Methyl ethyl (meth) acrylate, methoxytripropylene glycol (meth) acrylate, methoxytetrapropylene glycol (meth) acrylate, methoxypolypropylene glycol (meth) acrylate DOO, although polyoxypropylene such as polypropylene glycol mono (meth) acrylate (meth) acrylate monomer and the like, the present invention is not limited only to those exemplified. These polyoxyalkylene (meth) acrylate monomers may be used alone or in combination of two or more. In the present specification, “(meth) acrylate” means “acrylate” and / or “methacrylate”.
- the sugar skeleton-containing monomer has a property of suppressing cell adhesion to the resulting polymer.
- examples of the sugar skeleton-containing monomer include glucosylethyl (meth) acrylate and glucosylureaethyl (meth) acrylate, but the present invention is not limited to such examples. These sugar skeleton-containing monomers may be used alone or in combination of two or more.
- the phosphobetaine monomer has a property of suppressing the adhesion of cells to the obtained polymer.
- Examples of the phosphobetaine monomer include 2- (meth) acryloyloxyethyl phosphocholine, but the present invention is not limited to such examples. These phosphobetaine monomers may be used alone or in combination of two or more.
- the sulfobetaine monomer has the property of assisting the cells to adhere to the resulting polymer.
- examples of the sulfobetaine monomer include N- (meth) acryloyloxyethyl-N, N-dimethylammonium-N-propylsulfobetaine, but the present invention is limited only to such examples. is not. These sulfobetaine monomers may be used alone or in combination of two or more.
- the ratio between the nitrogen atom-containing monomer and the copolymerizable monomer [nitrogen atom-containing monomer / copolymerizable monomer is preferably 1/99 or more, more preferably 3/97 or more, still more preferably 5/95 or more, and particularly preferably 10/90 or more. From the viewpoint of sufficiently imparting the properties due to the polymerizable monomer, it is preferably 99/1 or less, preferably 97/3 or less, more preferably 95/5 or less, and still more preferably 90/10 or less.
- biocompatibility means a property in which proteins are difficult to be adsorbed.
- the monomer component used in the present invention contains a nitrogen atom-containing monomer and, if necessary, a copolymerizable monomer.
- the nitrogen atom-containing monomer and the copolymer can be used as long as the object of the present invention is not impaired.
- a monomer copolymerizable with the polymerizable monomer may be contained.
- Typical examples of the monomer copolymerizable with the nitrogen atom-containing monomer and the copolymerizable monomer include monomers having a carbon-carbon unsaturated double bond.
- Examples of the monomer having a carbon-carbon unsaturated double bond include a styrene monomer and a carboxylic acid ester monomer, but the present invention is not limited to such examples. Absent. These copolymerizable monomers may be used alone or in combination of two or more.
- styrene monomer When a styrene monomer is contained in the monomer component, there is an advantage that the heat resistance of the resulting polymer can be improved.
- the styrenic monomer include styrene, ⁇ -methylstyrene, ⁇ -hydroxystyrene, p-hydroxystyrene, and the like, but the present invention is not limited to such examples. These styrene monomers may be used alone or in combination of two or more.
- carboxylic acid ester monomers include methyl (meth) acrylate, ethyl (meth) acrylate, propyl (meth) acrylate, n-butyl (meth) acrylate, isobutyl (meth) acrylate, ( Tert-butyl (meth) acrylate, neopentyl (meth) acrylate, cyclohexyl (meth) acrylate, octyl (meth) acrylate, lauryl (meth) acrylate, stearyl (meth) acrylate, cetyl (meth) acrylate, Such as ethyl carbitol (meth) acrylate, hydroxyethyl (meth) acrylate, hydroxypropyl (meth) acrylate, hydroxybuty
- (Meth) acrylic acid alkyl ester, (meth) acrylic acid hydroxyalkyl ester, (meth) acrylic Examples include acid alkoxyalkyl esters, (meth) acrylic acid aralkyl esters, methyl itaconate, ethyl itaconate, vinyl acetate, vinyl propionate, etc., but the present invention is not limited to such examples. . These carboxylic acid ester monomers may be used alone or in combination of two or more.
- the polymerization initiator include (11- (2-bromo-2-methyl) propionyloxy) undecyltrichlorosilane, (4- (2-bromo-2-methyl) propionyloxy) butyltrichlorosilane, (6- Organosilane polymerization initiators such as (2-bromo-2-methyl) propionyloxy) hexyltrichlorosilane, (8- (2-bromo-2-methyl) propionyloxy) octyltrichlorosilane; azobisisobutyronitrile, Azo polymerization initiators such as azoisobutyronitrile, methyl azoisobutyrate, azobisdimethylvaleronitrile; peroxide polymerization initiators such as benzoyl peroxide; persulfate polymerization initiators such as potassium persulfate and ammoni
- the organic silane type polymerization initiator may be attached to a substrate in advance.
- the organosilane polymerization initiator is previously adhered to the base material, there is an advantage that the polymer coating layer to be formed can be firmly fixed on the surface of the base material.
- the amount of the polymerization initiator is not particularly limited, but is usually preferably 0.001 to 10 mol, more preferably 0.01 to 5 mol, per 100 mol of the monomer component.
- a chain transfer agent may be used when the monomer component is polymerized.
- the chain transfer agent can be used usually by mixing with a monomer component.
- examples of the chain transfer agent include mercaptan group-containing compounds such as lauryl mercaptan, dodecyl mercaptan, and thioglycerol, and inorganic salts such as sodium hypophosphite and sodium hydrogen sulfite. It is not limited. These chain transfer agents may be used alone or in combination of two or more.
- the amount of the chain transfer agent is not particularly limited, but is usually about 0.01 to 10 parts by mass per 100 parts by mass of the monomer component.
- Examples of the method for polymerizing the monomer component include a solution polymerization method, but the present invention is not limited to such examples.
- a coating layer can be formed on the surface of a base material by polymerizing the monomer component on the surface of the base material.
- the monomer component is polymerized by a solution polymerization method, for example, the monomer component and the polymerization initiator are dissolved in a solvent, and the monomer component is polymerized by immersing the substrate in the obtained solution.
- a polymer coating layer can be formed on the surface of the substrate.
- the base material having a polymer coating layer on the surface is coated with the monomer component on the base material surface, irradiated with light, or heated to polymerize the monomer component, It can also be produced by forming a polymer coating on the substrate surface.
- the solvent examples include water, alcohols such as methyl alcohol, ethyl alcohol, isopropyl alcohol, ethylene glycol, and propylene glycol, ketones such as acetone and methyl ethyl ketone, ethers such as diethyl ether and tetrahydrofuran, benzene, toluene, and xylene.
- Organic solvents such as aromatic hydrocarbon compounds, aliphatic hydrocarbon compounds such as n-hexane, alicyclic hydrocarbon compounds such as cyclohexane, and acetic acid esters such as methyl acetate and ethyl acetate can be mentioned. It is not limited to illustration only. These solvents may be used alone or in combination of two or more.
- the organic solvent is preferably degassed in advance with an inert gas such as nitrogen gas or argon gas from the viewpoint of smoothly proceeding the polymerization reaction of the monomer components.
- the amount of the solvent is usually preferably adjusted so that the concentration of the monomer component in the solution obtained by dissolving the monomer component in the solvent is about 10 to 80% by mass.
- monovalent copper salts such as copper bromide and copper chloride
- polyvalent bases such as bipyridyl and trisaminodiethylamine
- freeness such as ethyl-2-bromoisobutyrate A polymerization initiator or the like may coexist.
- the polymerization conditions such as the polymerization temperature and polymerization time for polymerizing the monomer component are preferably adjusted as appropriate according to the composition of the monomer component, the type and amount of the polymerization initiator, and the like.
- the atmosphere when the monomer component is polymerized is preferably an inert gas.
- the inert gas include nitrogen gas and argon gas, but the present invention is not limited to such examples.
- the weight average molecular weight of the polymer obtained by polymerizing the monomer component as described above is preferably 1000 or more in consideration of the rheological properties of the polymer and the balance between the hydrophilicity and hydrophobicity of the polymer. More preferably, it is 5000 or more, and from the viewpoint of enhancing the solubility in a solvent, it is preferably 1000000 or less, more preferably 100000 or less, and even more preferably 50000 or less.
- the weight average molecular weight of the polymer can be measured, for example, by gel permeation chromatography.
- a material of a base material for example, polyamide represented by glass, polyethylene, polypropylene, polystyrene, polyvinyl chloride, nylon, polyimide, polyurethane, urea resin, polylactic acid, polyvinyl alcohol, polyvinyl acetate, acrylic resin, Polysulfone, polycarbonate, ABS resin, AS resin, silicone resin, ceramic, metal, and the like can be mentioned, but the present invention is not limited to such examples.
- the substrates made of these materials from the viewpoint of firmly fixing the polymer to the substrate, a substrate having a hydroxyl group on its surface is preferable, and a glass substrate such as a glass plate is more preferable.
- a glass substrate is used as the substrate, it is preferable that the glass substrate is previously subjected to a treatment such as ultraviolet treatment or ozone treatment from the viewpoint of improving the adhesion of the polymer.
- the surface is hydrophilized so that the hydroxyl group is present on the surface. It is preferable.
- a hydroxyl group is sufficiently present on the surface of a substrate made of glass or the like, it is not necessary to make the surface hydrophilic so that a hydroxyl group exists on the surface. Needless to say.
- the shape of the substrate differs depending on the use of the cell culture substrate and the like, it cannot be determined unconditionally, and therefore it is preferable to determine appropriately according to the use.
- Examples of the shape of the substrate include a film, a sheet, a plate, a rod, and a molded body formed into a predetermined shape.
- the present invention is not limited to such examples.
- the substrate on which the polymer coating layer is formed is washed with ethanol, water, etc., and dried using an inert gas such as nitrogen gas. It is preferable.
- the thickness of the polymer film formed on the surface of the material varies depending on the use of the cell culture substrate and cannot be determined unconditionally, but is usually about 10 nm to 10 ⁇ m. Preferably there is.
- the polymer coating layer irradiated with the ion beam is removed by irradiating the ion beam to a predetermined position of the coating layer of the substrate on which the polymer coating layer is formed on the surface.
- a predetermined position of the polymer coating layer is irradiated with an ion beam, the polymer at the portion irradiated with the ion beam is removed, so that a cell culture substrate having a predetermined polymer coating pattern is obtained.
- Examples of types of ions used in the ion beam include H + , Na + , C + , N + , N 2 + , O 2 + , Gd + , He + , Ne + , Ar + , Kr +, and the like. However, the present invention is not limited to such examples.
- the dose of ions by the ion beam is preferably 1 ⁇ 10 13 ⁇ 1 ⁇ 10 16 pieces / cm 2, 1 ⁇ 10 More preferably, it is 13 to 1 ⁇ 10 15 pieces / cm 2 .
- the acceleration voltage by the ion beam is preferably about 50 to 200 kV.
- the current density of the ion beam is usually preferably 0.5 ⁇ A / cm 2 or less.
- the cells are cultured using the cell culture substrate from which the polymer coating layer irradiated with the ion beam has been removed by irradiating the ion beam to a predetermined position of the coating layer of the substrate as described above,
- the cells are cultured because the polymer is not present at the location irradiated with the ion beam, but the cells are not cultured at the location where the polymer is present without being irradiated with the ion beam.
- the cells can be cultured.
- a cell culture substrate capable of regenerating cells having a shape corresponding to the shape of a tissue to be regenerated by an animal such as a human is obtained. If this cell culture substrate is used, the cells can be cultured in an arbitrary shape. Therefore, the cells can be cultured in a predetermined shape (pattern) using the cell culture substrate in a medical field such as regenerative medicine.
- Example 1 1.82 g (4 mmol) of (11- (2-bromo-2-methyl) propionyloxy) undecyltrichlorosilane was dissolved in 15 mL of toluene to prepare a polymerization initiator solution.
- a glass plate (vertical: 24 mm, horizontal: 12 mm, thickness: 1 mm) washed by irradiating ultraviolet rays and ozone on each side for 1 hour each is put into a 100 mL sample bottle, and the polymerization initiator solution obtained above was added so that the glass plate was completely immersed in the sample bottle.
- the opening of the sample bottle was covered and allowed to stand at room temperature for 18 hours, and then the glass plate was taken out of the sample bottle, washed with toluene, and dried with nitrogen gas.
- the weight average molecular weight of the polymer obtained above was determined based on the following method. That is, in a 100 mL sample bottle, 30.9 mg (0.2143 mmol) of copper bromide, 67.0 mg (0.4286 mmol) of 2,2′-bipyridyl, N-methacryloyloxyethyl-N, N-dimethylammonium- ⁇ After adding 1.007 g (4.317 mmol) of -N-methylcarboxybetaine and 32 ⁇ L (0.2143 mmol) of ethyl-2-bromoisobutyrate as a free polymerization initiator, 10 mL of methanol degassed with argon gas was added. It was.
- the weight average molecular weight of the obtained polymer was 15600 as measured by gel permeation chromatography.
- the glass plate on which the polymer coating layer obtained above was formed was irradiated with an ion beam in a heart shape of 200 ⁇ m in length and 200 ⁇ m in width.
- Gd + was irradiated at an acceleration voltage of 50 kV at 1 ⁇ 10 14 ions / cm 2 .
- the glass plate irradiated with the ion beam was placed in a petri dish having a diameter of 35 mm, and 5 ⁇ 10 5 HEK-293 cells were mixed with 1% antibiotics in the petri dish and adjusted with fetal bovine serum. (Dulbecco's Modified Eagle Medium with FBS) was cultured in an atmosphere of 5% by volume carbon dioxide at 37 ° C. until it reached 70% confluency. As a result, HEK-293 cell growth was observed only in the portion where the coating layer was removed by ion beam irradiation.
- Example 1 the polymer obtained by polymerizing the monomer component containing the nitrogen atom-containing monomer represented by the formula (I) was coated on a glass plate, By irradiating a predetermined position of the polymer coating layer with an ion beam and removing the polymer coating layer irradiated with the ion beam, cells can be grown only in the portion where the coating layer has been removed. Therefore, it can be seen that a cell culture substrate capable of culturing cells in an arbitrary shape is obtained.
- Example 2 In Example 1, instead of 1.007 g (4.317 mmol) of N-methacryloyloxyethyl-N, N-dimethylammonium- ⁇ -N-methylcarboxybetaine, N-methacryloyloxyethyl-N, N-dimethylammonium- The same operation as in Example 1 was carried out except that 0.5035 g (2.159 mmol) of ⁇ -N-methylcarboxybetaine and 0.2440 g (2.159 mmol) of N-isopropylacrylamide were used. As a result, HEK-293 cell growth was observed only in the portion where the coating layer was removed by ion beam irradiation.
- the polymer a copolymer of N-methacryloyloxyethyl-N, N-dimethylammonium- ⁇ -N-methylcarboxybetaine and N-isopropylacrylamide was used, and the coating layer was obtained in the same manner as in Example 1.
- the coating layer was obtained in the same manner as in Example 1.
- Example 3 In Example 1, instead of 1.007 g (4.317 mmol) of N-methacryloyloxyethyl-N, N-dimethylammonium- ⁇ -N-methylcarboxybetaine, N-methacryloyloxyethyl-N, N-dimethylammonium- The same operation as in Example 1 was carried out except that 0.5035 g (2.159 mmol) of ⁇ -N-methylcarboxybetaine and 0.2807 g (2.159 mmol) of 2-methoxyethyl methacrylate were used. As a result, HEK-293 cell growth was observed only in the portion where the coating layer was removed by ion beam irradiation.
- Example 4 In Example 1, instead of 1.007 g (4.317 mmol) of N-methacryloyloxyethyl-N, N-dimethylammonium- ⁇ -N-methylcarboxybetaine, N-methacryloyloxyethyl-N, N-dimethylammonium- The same operation as in Example 1 was carried out except that 0.5035 g (2.159 mmol) of ⁇ -N-methylcarboxybetaine and 0.7211 g (2.159 mmol) of glucosylethyl methacrylate were used. As a result, HEK-293 cell growth was observed only in the portion where the coating layer was removed by ion beam irradiation.
- the polymer a copolymer of N-methacryloyloxyethyl-N, N-dimethylammonium- ⁇ -N-methylcarboxybetaine and glucosylethyl methacrylate was used, and the coating layer was formed in the same manner as in Example 1.
- the coating layer was formed in the same manner as in Example 1.
- Example 5 In Example 1, instead of 1.007 g (4.317 mmol) of N-methacryloyloxyethyl-N, N-dimethylammonium- ⁇ -N-methylcarboxybetaine, N-methacryloyloxyethyl-N, N-dimethylammonium- The same operation as in Example 1 was performed, except that 0.5035 g (2.159 mmol) of ⁇ -N-methylcarboxybetaine and 0.5095 g (2.159 mmol) of 2-methacryloloxyethylphosphocholine were used. . As a result, HEK-293 cell growth was observed only in the portion where the coating layer was removed by ion beam irradiation.
- Example 1 a copolymer of N-methacryloyloxyethyl-N, N-dimethylammonium- ⁇ -N-methylcarboxybetaine and 2-methacrylolyloxyethylphosphocholine was used as the polymer, and Example 1 Similarly, by irradiating a predetermined position of the coating layer with an ion beam and removing the coating layer of the copolymer irradiated with the ion beam, cells can be grown only on the portion where the coating layer has been removed. Thus, it can be seen that a cell culture substrate capable of culturing cells in an arbitrary shape can be obtained.
- Example 6 In Example 1, instead of 1.007 g (4.317 mmol) of N-methacryloyloxyethyl-N, N-dimethylammonium- ⁇ -N-methylcarboxybetaine, N-methacryloyloxyethyl-N, N-dimethylammonium- Except for using 0.5035 g (2.159 mmol) of ⁇ -N-methylcarboxybetaine and 0.462 g (2.159 mmol) of N-methacryloyloxyethyl-N, N-dimethylammonium-N-propylsulfobetaine The same operation as in Example 1 was performed. As a result, HEK-293 cell growth was observed only in the portion where the coating layer was removed by ion beam irradiation.
- a copolymer of N-methacryloyloxyethyl-N, N-dimethylammonium- ⁇ -N-methylcarboxybetaine and N-methacryloyloxyethyl-N, N-dimethylammonium-N-propylsulfobetaine was used as a polymer.
- Comparative Example 1 100 g of ⁇ -methacryloyloxypropyltrimethoxysilane (manufactured by Shin-Etsu Chemical Co., Ltd., trade name: KBM-503) and 400 g of ethyl alcohol were added to a 1 L Kolben equipped with a nitrogen gas introduction tube, a condenser and a stirrer. . After deaeration by depressurizing the inside of the Kolben, nitrogen gas was introduced into the Kolben and returned to normal pressure.
- the glass substrate (length: 38 mm, width: 26 mm, thickness: 1 mm) was washed with water, methanol and acetone in this order, and then both surfaces were irradiated with ultraviolet rays and washed with ozone for 1 hour.
- a solution prepared by diluting the resin composition for a cell culture substrate obtained above with ethyl alcohol and adjusting the concentration to 1% by volume is prepared, and the substrate is immersed in this solution, and then at room temperature.
- the cell culture substrate was prepared by allowing the substrate to stand for 10 minutes and forming a coating film made of the resin composition for cell culture substrate on the substrate surface.
- the obtained cell culture substrate was taken out of the solution, washed with ethyl alcohol and purified water, and then dried with nitrogen gas to obtain a glass plate on which a polymer coating layer was formed.
- the glass plate on which the polymer coating layer obtained above was formed was irradiated with an ion beam in a heart shape in the same manner as in Example 1 to culture HEK-293 cells.
- HEK-293 cell growth was observed not only in the portion where the coating layer was removed by irradiation with the ion beam but also in the portion where the polymer was coated.
- the cell culture substrate production method of the present invention provides a cell culture substrate capable of regenerating cells having a shape corresponding to the shape of the tissue to be regenerated. Since this cell culture substrate can be used to culture cells in an arbitrary shape, the cell culture substrate includes embryonic stem cells (ES cells), interstitial cells, induced pluripotent stem cells (iPS cells), It is expected to be used when culturing precursor cells in a predetermined shape.
- ES cells embryonic stem cells
- iPS cells induced pluripotent stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
Description
(1) 基材の表面上に重合体の被覆層が形成された細胞培養基材の製造方法であって、前記重合体が式(I):
で表わされる窒素原子含有単量体を含有する単量体成分を重合させてなる重合体であり、前記重合体の被覆層の所定位置にイオンビームを照射することによって当該イオンビームが照射された重合体の被覆層を除去することを特徴とする細胞培養基材の製造方法、
(2) 単量体成分が、さらに、アルキル(メタ)アクリルアミド系単量体、ポリオキシアルキレン(メタ)アクリレート系単量体、糖骨格含有単量体、ホスホベタイン系単量体およびスルホベタイン系単量体からなる群より選ばれた少なくとも1種の共重合性単量体を含有する前記(1)に記載の細胞培養基材の製造方法、
(3) 基材の表面上で単量体成分を重合させることによって重合体の被覆層を形成する前記(1)または(2)に記載の細胞培養基材の製造方法、ならびに
(4) 前記(1)~(3)のいずれかに記載の細胞培養基材の製造方法によって得られた細胞培養基材
に関する。
で表わされる窒素原子含有単量体を含有する単量体成分を重合させることによって得られる重合体であり、前記重合体の被覆層の所定位置にイオンビームを照射することによって当該イオンビームが照射された重合体の被覆層を除去することを特徴とする。
Yは、酸素原子または-NH-基である。
(11-(2-ブロモ-2-メチル)プロピオニルオキシ)ウンデシルトリクロロシラン1.82g(4mmol)をトルエン15mLに溶解させ、重合開始剤溶液を調製した。
実施例1において、N-メタクリロイルオキシエチル-N,N-ジメチルアンモニウム-α-N-メチルカルボキシベタイン1.007g(4.317mmol)の代わりに、N-メタクリロイルオキシエチル-N,N-ジメチルアンモニウム-α-N-メチルカルボキシベタイン0.5035g(2.159mmol)およびN-イソプロピルアクリルアミド0.2440g(2.159mmol)を用いたこと以外は、実施例1と同様の操作を行なった。その結果、イオンビームを照射することによって被覆層が除去された部分にのみHEK-293細胞の成長が見られた。
実施例1において、N-メタクリロイルオキシエチル-N,N-ジメチルアンモニウム-α-N-メチルカルボキシベタイン1.007g(4.317mmol)の代わりに、N-メタクリロイルオキシエチル-N,N-ジメチルアンモニウム-α-N-メチルカルボキシベタイン0.5035g(2.159mmol)および2-メトキシエチルメタクリレート0.2807g(2.159mmol)を用いたこと以外は、実施例1と同様の操作を行なった。その結果、イオンビームを照射することによって被覆層が除去された部分にのみHEK-293細胞の成長が見られた。
実施例1において、N-メタクリロイルオキシエチル-N,N-ジメチルアンモニウム-α-N-メチルカルボキシベタイン1.007g(4.317mmol)の代わりに、N-メタクリロイルオキシエチル-N,N-ジメチルアンモニウム-α-N-メチルカルボキシベタイン0.5035g(2.159mmol)およびグルコシルエチルメタクリレート0.7211g(2.159mmol)を用いたこと以外は、実施例1と同様の操作を行なった。その結果、イオンビームを照射することによって被覆層が除去された部分にのみHEK-293細胞の成長が見られた。
実施例1において、N-メタクリロイルオキシエチル-N,N-ジメチルアンモニウム-α-N-メチルカルボキシベタイン1.007g(4.317mmol)の代わりに、N-メタクリロイルオキシエチル-N,N-ジメチルアンモニウム-α-N-メチルカルボキシベタイン0.5035g(2.159mmol)および2-メタクリロリルオキシエチルホスホコリン0.5095g(2.159mmol)を用いたこと以外は、実施例1と同様の操作を行なった。その結果、イオンビームを照射することによって被覆層が除去された部分にのみHEK-293細胞の成長が見られた。
実施例1において、N-メタクリロイルオキシエチル-N,N-ジメチルアンモニウム-α-N-メチルカルボキシベタイン1.007g(4.317mmol)の代わりに、N-メタクリロイルオキシエチル-N,N-ジメチルアンモニウム-α-N-メチルカルボキシベタイン0.5035g(2.159mmol)およびN-メタクリロイルオキシエチル-N,N-ジメチルアンモニウム-N-プロピルスルホベタイン0.462g(2.159mmol)を用いたこと以外は、実施例1と同様の操作を行なった。その結果、イオンビームを照射することによって被覆層が除去された部分にのみHEK-293細胞の成長が見られた。
窒素ガス導入管、コンデンサーおよび撹拌機を備えた1L容のコルベンに、γ-メタクリロイルオキシプロピルトリメトキシシラン〔信越化学工業(株)製、商品名:KBM-503〕100gおよびエチルアルコール400gを添加した。コルベン内を減圧することによって脱気した後、窒素ガスをコルベン内に導入して常圧に戻した。
Claims (4)
- 単量体成分が、さらに、アルキル(メタ)アクリルアミド系単量体、ポリエチレングリコール系単量体、ポリプロピレングリコール系単量体、糖骨格含有単量体、ホスホベタイン系単量体およびスルホベタイン系単量体からなる群より選ばれた少なくとも1種の共重合性単量体を含有する請求項1に記載の細胞培養基材の製造方法。
- 基材の表面上で単量体成分を重合させることによって重合体の被覆層を形成する請求項1または2に記載の細胞培養基材の製造方法。
- 請求項1~3のいずれかに記載の細胞培養基材の製造方法によって得られた細胞培養基材。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012531871A JP5887272B2 (ja) | 2010-08-31 | 2011-08-30 | 細胞培養基材の製造方法 |
US13/820,037 US9434927B2 (en) | 2010-08-31 | 2011-08-30 | Method for manufacturing cell culture substrate |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010194911 | 2010-08-31 | ||
JP2010-194911 | 2010-08-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2012029731A1 true WO2012029731A1 (ja) | 2012-03-08 |
Family
ID=45772817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2011/069510 WO2012029731A1 (ja) | 2010-08-31 | 2011-08-30 | 細胞培養基材の製造方法 |
Country Status (3)
Country | Link |
---|---|
US (1) | US9434927B2 (ja) |
JP (1) | JP5887272B2 (ja) |
WO (1) | WO2012029731A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013172292A1 (ja) * | 2012-05-12 | 2013-11-21 | 国立大学法人北海道大学 | 水性ゲル |
JP2015221851A (ja) * | 2014-05-22 | 2015-12-10 | 積水化学工業株式会社 | 粘着剤組成物、細胞支持用基材、細胞培養用基材、並びに、細胞の培養方法 |
WO2018168309A1 (ja) * | 2017-03-15 | 2018-09-20 | Jsr株式会社 | 感放射線性樹脂組成物、パターン膜およびその製造方法、パターン基板、細胞培養器具、マイクロ流路デバイス、ならびに細胞塊の製造方法 |
JP2021158968A (ja) * | 2020-03-31 | 2021-10-11 | 株式会社朝日Fr研究所 | 細胞接着性の親水性改質細胞培養基材 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0284174A (ja) * | 1988-06-22 | 1990-03-26 | Dainippon Printing Co Ltd | 細胞培養基板およびその製法 |
JP2003082119A (ja) * | 2001-09-10 | 2003-03-19 | Inst Of Physical & Chemical Res | 細胞回収膜およびその製造方法 |
JP2005052011A (ja) * | 2003-08-04 | 2005-03-03 | Institute Of Physical & Chemical Research | マイクロパターン化細胞基質およびその製造方法 |
JP2010057745A (ja) * | 2008-09-04 | 2010-03-18 | Osaka Organic Chem Ind Ltd | 医療用材料 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7919305B2 (en) * | 2004-02-19 | 2011-04-05 | Dai Nippon Printing Co., Ltd. | Method for manufacturing cell culture substrate |
-
2011
- 2011-08-30 US US13/820,037 patent/US9434927B2/en active Active
- 2011-08-30 WO PCT/JP2011/069510 patent/WO2012029731A1/ja active Application Filing
- 2011-08-30 JP JP2012531871A patent/JP5887272B2/ja active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0284174A (ja) * | 1988-06-22 | 1990-03-26 | Dainippon Printing Co Ltd | 細胞培養基板およびその製法 |
JP2003082119A (ja) * | 2001-09-10 | 2003-03-19 | Inst Of Physical & Chemical Res | 細胞回収膜およびその製造方法 |
JP2005052011A (ja) * | 2003-08-04 | 2005-03-03 | Institute Of Physical & Chemical Research | マイクロパターン化細胞基質およびその製造方法 |
JP2010057745A (ja) * | 2008-09-04 | 2010-03-18 | Osaka Organic Chem Ind Ltd | 医療用材料 |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013172292A1 (ja) * | 2012-05-12 | 2013-11-21 | 国立大学法人北海道大学 | 水性ゲル |
US9976000B2 (en) | 2012-05-12 | 2018-05-22 | National University Corp. Hokkaido University | Aqueous gel |
JP2015221851A (ja) * | 2014-05-22 | 2015-12-10 | 積水化学工業株式会社 | 粘着剤組成物、細胞支持用基材、細胞培養用基材、並びに、細胞の培養方法 |
WO2018168309A1 (ja) * | 2017-03-15 | 2018-09-20 | Jsr株式会社 | 感放射線性樹脂組成物、パターン膜およびその製造方法、パターン基板、細胞培養器具、マイクロ流路デバイス、ならびに細胞塊の製造方法 |
JPWO2018168309A1 (ja) * | 2017-03-15 | 2020-01-16 | Jsr株式会社 | 感放射線性樹脂組成物、パターン膜およびその製造方法、パターン基板、細胞培養器具、マイクロ流路デバイス、ならびに細胞塊の製造方法 |
JP7070543B2 (ja) | 2017-03-15 | 2022-05-18 | Jsr株式会社 | 感放射線性樹脂組成物、パターン膜およびその製造方法、パターン基板、細胞培養器具、マイクロ流路デバイス、ならびに細胞塊の製造方法 |
JP2021158968A (ja) * | 2020-03-31 | 2021-10-11 | 株式会社朝日Fr研究所 | 細胞接着性の親水性改質細胞培養基材 |
JP7323182B2 (ja) | 2020-03-31 | 2023-08-08 | 株式会社朝日Fr研究所 | 細胞接着性の親水性改質細胞培養基材 |
Also Published As
Publication number | Publication date |
---|---|
US20130224861A1 (en) | 2013-08-29 |
US9434927B2 (en) | 2016-09-06 |
JPWO2012029731A1 (ja) | 2013-10-28 |
JP5887272B2 (ja) | 2016-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1829896B1 (en) | Process for production of organic-inorganic hybrid hydrogel, cell culture substrate comprising the same, and antifogging material comprising dried product thereof | |
JP5349873B2 (ja) | 医療用材料 | |
JP5871000B2 (ja) | ポリマー及びその製造方法 | |
JP7319349B2 (ja) | 細胞培養基材 | |
JP7315653B2 (ja) | 細胞培養基材 | |
JP5887272B2 (ja) | 細胞培養基材の製造方法 | |
JP6447787B2 (ja) | 細胞培養基材 | |
JP2013079306A (ja) | 二液型防曇剤 | |
JP2011072297A (ja) | 細胞培養基材 | |
JP4979199B2 (ja) | 細胞培養基材及び細胞培養方法 | |
JP5674378B2 (ja) | 生体適合性材料 | |
WO2020066685A1 (ja) | タンパク質付着抑制用共重合体、共重合体の製造方法、樹脂改質剤、成形材料、共重合体含有組成物、塗膜および物品 | |
JP2014043567A (ja) | 生体不活性膜、コーティング液、およびその製造方法ならびに生体不活性処理済基材 | |
JP2018009137A (ja) | 重合体、コーティング組成物、および物品 | |
JP6314458B2 (ja) | 温度応答性を有する細胞培養基材およびその製造方法 | |
JP7459616B2 (ja) | 共重合体、医療用コーティング剤及び医療機器 | |
WO2021256377A1 (en) | Cell culture substrate | |
JP7348280B2 (ja) | 細胞培養基材 | |
JP7183612B2 (ja) | 多能性幹細胞の培養基材及び多能性幹細胞の製造方法 | |
JP5450122B2 (ja) | 有機無機複合体 | |
JP6229503B2 (ja) | 温度応答性を有する細胞培養基材およびその製造方法 | |
JP6003594B2 (ja) | 温度応答性を有する細胞培養基材の製造方法 | |
JP6229502B2 (ja) | 温度応答性を有する細胞培養基材の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11821747 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2012531871 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13820037 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11821747 Country of ref document: EP Kind code of ref document: A1 |